Human regulatory T cells in allogeneic stem cell transplantation.
about
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseNovel regulatory therapies for prevention of Graft-versus-host disease.Human regulatory T cells of G-CSF mobilized allogeneic stem cell donors qualify for clinical application.Injury-induced MRP8/MRP14 stimulates IP-10/CXCL10 in monocytes/macrophagesGranzyme A Is Required for Regulatory T-Cell Mediated Prevention of Gastrointestinal Graft-versus-Host DiseaseIncreased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation.Peripherally circulating CD4⁺ FOXP3⁺ CXCR3⁺ T regulatory cells correlate with renal allograft function.Predictors of immunosuppressive regulatory T lymphocytes in healthy women.Nonviral delivery of small interfering RNA into pancreas-associated immune cells prevents autoimmune diabetes.Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.Therapeutic potential of induced and natural FoxP3(+) regulatory T cells for the treatment of Graft-versus-host disease.New ways to separate graft-versus-host disease and graft-versus-tumour effects after allogeneic haematopoietic stem cell transplantation.Promoting transplantation tolerance; adoptive regulatory T cell therapy.Homeostatic control of regulatory T cell diversity.Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis.Inhibition of activation induced CD154 on CD4+ CD25- cells: a valid surrogate for human Treg suppressor function.Reconstitution and phenotype of Tregs in CMV reactivating patients following allogeneic hematopoietic stem cell transplantation.Comprehensive phenotyping of regulatory T cells after liver transplantation.Tregs, HSCT, and acute GVHD: up close and personal.Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells.Human T cells depend on functional calcineurin, tumour necrosis factor-α and CD80/CD86 for expansion and activation in mice.Reconstitution of maturating and regulatory lymphocyte subsets after cord blood and BMT in children.Neuropilin-1+ regulatory T cells promote skin allograft survival and modulate effector CD4+ T cells phenotypic signature.Optimizing human Treg immunotherapy by Treg subset selection and E-selectin ligand expression.Pre-transplant donor CD4− invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host diseasegeneration of umbilical cord blood T regulatory cells expressing the homing markers CD62L and cutaneous lymphocyte antigen
P2860
Q28076264-186695C4-AE71-4D51-89EB-5C145E9D6FD7Q34269481-1056C893-9B10-447D-AD90-1CD22676D2D1Q34517083-916876E7-BF0E-4834-B582-44214157F09CQ34847755-FD415D1B-D8D3-4CB8-959F-325DE905319BQ35619237-91398699-7362-4D16-8465-ED3913F9D16AQ36036340-D017D59B-6DE8-4949-8464-AAB43F2004AFQ36183387-0AE36DB3-6699-4CE4-A4F4-051D411396CDQ36206608-F74F97E6-DC18-45A8-8097-423DCA8BAD67Q36460478-F1D35312-B7B6-4797-848B-3B31AFDDB8C0Q36904560-B2D302D3-3C25-4A13-ACEF-11B7808AC921Q38000048-79029972-609A-452D-AEDB-0C8EB4D23435Q38057376-BCC41D67-C87D-41CF-82AA-621FB7818A37Q38097917-8A62E56F-EBAF-4B25-8798-3B56698218A6Q38183674-571EAAF3-B069-42F2-BB2D-2ACA4A55FE94Q39037369-B1E20248-DCA8-42D2-9AF8-CD4D26A3450BQ39332952-5DA0C007-4688-40B6-938D-940981C1E9B2Q39533852-49B399AB-A732-47B8-8947-D77A6BC41687Q41632625-A0B2B3FB-D9B2-4FD4-B675-02BB200C16BFQ41839097-6EB91A7C-F159-464E-B0BA-06B2B6986B54Q42175189-103FEDF5-2B47-4F33-8747-17DE1BA0C2B9Q43514712-14FB39D7-1F94-4F72-9074-67D3E1B68382Q45403029-E34C5812-AC57-4A49-B58A-7807C89CDDD9Q46210096-07BCC31D-511E-4C15-98EB-BB1E14629AD1Q49702312-A437F347-82D5-43D4-A75E-E38DC08C6DF4Q57216449-21615A0E-582F-4863-8814-E14BD54D7BAAQ58739873-B2F3900F-7F68-4048-87AC-AB38D62A4B44
P2860
Human regulatory T cells in allogeneic stem cell transplantation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Human regulatory T cells in allogeneic stem cell transplantation.
@en
Human regulatory T cells in allogeneic stem cell transplantation.
@nl
type
label
Human regulatory T cells in allogeneic stem cell transplantation.
@en
Human regulatory T cells in allogeneic stem cell transplantation.
@nl
prefLabel
Human regulatory T cells in allogeneic stem cell transplantation.
@en
Human regulatory T cells in allogeneic stem cell transplantation.
@nl
P2093
P1433
P1476
Human regulatory T cells in allogeneic stem cell transplantation
@en
P2093
Anke Franzke
Arnold Ganser
Dunja Bruder
Jens Grosse
Michael Stadler
Robert Geffers
Sarvari Velaga
Stefanie Buchholz
Sya N Ukena
P304
P356
10.1182/BLOOD-2011-05-352708
P407
P50
P577
2011-07-21T00:00:00Z